We examined the effect of the human T lymphotropic virus type 1 (HTLVI) Tax gene product on the human transforming growth factor 01(TGF-01) promoter. Transfection of deleted constructs of the TGF-fl1 promoter revealed regions homologous with AP-1 binding sites that were required for Tax-induced transactivation of the TGF-(31 promoter. In addition, we examined the expression and secretion of TGF-,3 in fresh leukemic cells isolated from patients with adult T cell leukemia (ATL) and in HTLV1-infected T cell lines . We report that fresh leukemic cells from ATL patients constitutively produce high levels of TGF-01 mRNA and secrete TGF-a1 but not TGF-/32 into the culture medium. In addition, long-term ATL cell lines expressed significant amounts of TGF-/31 mRNA as well as detectable levels of TGF-01 protein . These results suggest a role for Tax in the upregulation of TGF-a1 in HTLVI-infected cells.
toxic T cells (19) (20) (21) (22) (23) (24) (25) . There is evidence that TGF-a may be immunosuppressive in vivo as well. patients with glioblastomas often have impaired cell-mediated immune responses, and their serum can inhibit mitogen-and antigen-induced proliferation of normal T cells (26) ; surgical removal of the tumor reversed the immunosuppression . Purification of the immunesuppressive factor from a ghoblastoma cell line revealed it to be TGF-S2, a protein closely related to TGF-,81, with nearly identical biological properties. It has been postulated that TGFLO may also be involved in bone resorption since TGF-a activity is increased in cultures of fetal rat calvarial cells incubated with agents known to stimulate bone resorption, such as parathyroid hormone, vitamin D3, and ID1 (17) .
In this study, we have confirmed the overproduction of TGF-O by freshly isolated ATL cells (14) and have demonstrated that the TGF-# isoform secreted by these cells is exclusively TGF-#1 . Moreover, since the TGF-01 promoter was found to be transactivated by the HTLV I p40x (Tax) protein (27) (28) (29) , we suggest that this may be a potential mechanism by which TGF-a production is increased in ATL cells. The specific sequence in the 5' regulatory region of the TGF-0 promoter responsive to Tax was delineated by the use of deletion mutants and matched a consensus binding site for the transcriptional factor AP-1.
The Journal of Experimental Medicine -Volume 172 July 1990 [121] [122] [123] [124] [125] [126] [127] [128] [129] Materials and Methods Cells. Venous blood anticoagulated with either EGTA, heparin, or citrate was diluted 1:1 with PBS and then underlayered with lymphocyte separation medium (Organon Technika, Durham, NC). Tubes were spun at 600 g for 30 min at room temperature. Interface cells were washed three times in serum-free RPMI 1640 and suspended in one of two serum-free media preparations. The preparations used were AIMV (Gibco Laboratories, Grand Island, NY) and Nutridoma-HU-supplemented (1 :100) RPMI 1640 . Cultures were done in T-25 tissue culture flasks prepared in the following manner : 10 ml of PBS/25% FCS was added to each flask, and flasks were allowed to lie flat for 30 min at room temperature. This solution was removed from the flask and they were then washed thoroughly with PBS. ATL PBMC were then introduced into the flask at cell densities of 1.8-6 x 106/ml and cultured for 48-96 h at 37°C, 95% air/5% CO,. Contents of the flask were removed and the cells were pelleted. The supernatants were spun again at 10,000 g for 15 min to remove residual cellular debris . With one of the ATL patients (ATL8), the PBMC were further purified to obtain a highly enriched leukemic population . After isolation, PBMC were depleted of monocytes by plastic adherence for 1 h at 37°C . The nonadherent lymphocytes were harvested and layered on 46 .5% Percoll (Pharmacia Fine Chemicals, Piscataway, NJ) and spun for 20 min at 600 g. The dense cells were harvested and washed. These dense cells were then rosetted with 2-aminoethylisothiouronium bromide (Sigma Chemical Co ., St . Louis, MO)-treated SRBC at a final concentration of 1% for 20 min at 37°C . This suspension was underlayered with LSM and spun for 20 min at 600 g. The red cells in the pellet were lysed and the lymphocytes were collected. This lymphocyte population was suspended in a small volume, to which the antibodies OKTS (anti-CD8) and 3AI (anti-CD7) were added at 5 ttg/ml in RPMI 1640/10% FCS. The suspension was incubated for 30 min at 4°C. Then, baby rabbit complement (Pel-Freez Biologicals, Rogers, AR) was added at 1 :3 (vol/vol), and the suspension was incubated for 90 min at 37°C. The cell suspension was then underlayered with lymphocyte separation medium and spun at 800 g for 12 min. The interface cells were collected and put in culture with RPMI 1640/Nutridoma, as described above. An aliquot of these cells was analyzed by FRCS and found to be >98.5% CD2', CD4', CD5', with <1% contamination with cells bearing the following markers: CD7, CD8, CD19, CD14, and CD16. In addition, there was strong uniform expression of CD25 (Tac) on >88% of these cells. The presence of a large predominance of CD2, CD4', CD25' cells with near absence of CD7' or CD8' cells indicates that there were few residual nonmalignant T cells in this population . Established HTLVI-infected T cell lines MT-1, MT-2, and MT-4 ; T cell lines established from the peripheral blood of ATL patients, HUT-102; andHTLV I-uninfected lines, Jurkat (Tcell line) and K-562 (human erythroleukemia), were cultured in RPMI 1640 medium with 10% (vol/vol) FCS. Human lung adenocarcinoma (A-549) cells were grown in DME with high glucose supplemented with 5% FCS.
Patient Population . Eight patients with a histologically confirmed diagnosis of ATL were studied. Each patient's diagnosis was established by the following criteria : (a) presence of a circulating pool of neoplastic mature T cells with indented nuclei ; (b) expression of the tx chain of the IL2-R on >20% of the circulating lymphocytes; (c) demonstration of a clonal integration of the HTLVI genome in the circulating lymphocytes, as well as a clonal rearrangement of the TCR ,B gene; and (d) presence of HTLV-1 antibodies in the serum.
Analysis of TGF01 mRNA and 7r-F-01-CAT mRNA Expression. PBMC from ATL patients were separated from heparinized venous blood by centrifugation over Ficoll-Hypaque. Cells were washed twice 122 Transactivation of the Transforming Growth Factor al Gene in RPMI 1640 and then lysed in a guanidinium thiocyanate solution . Total cellular RNA was isolated by the method of Chirgwin et al . (30) . Total RNAs from resting T cells, PHA-activated T cells, purified normal PBMC, normal B cells, and Staphylococcus aureus Cowan-activatedB cells were also isolated as described above. The levels of specific transcripts were analyzed by Northern blot analyses. Equal amounts of RNA (10 Ag), as confirmed by ethidium staining, were subjected to electrophoresis on 1% agarose gels containing 0.66 M formaldehyde, and were transferred to nitrocellulose membranes. Blots were hybridized using 3 2P-labeled probes according to the method of Church and Gilbert (31) . Labeling of the 218-bp single-stranded TGF-/91 probe, complementary to the mature coding region of human TGF-/31 mRNA, has been described (32) .
For the detection of chloramphenicol acetyltransferase (CAT) mRNA directed by TGF-01 promoters, the levels of specific transcripts were analyzed by the RNase protection technique. RNA probes were synthesized according to the instructions of the manufacturer (Promega Biotec, Madison, WI). The EcoRl fragment from the phTG7 (33) was removed and religated. This plasmid contains a 256-bp CAT fragment . This plasmid was linearized by HindIII digestion, and the linear plasmid was transcribed with SP6 polymerase. DNase I was added to digest the DNA template. The 456-nucleotide RNA probe contained 256 by of CAT coding sequence. Total RNA was harvested after transfection of TGF-01 promoter CAT constructs, together with a second plasmid expressing the HTLV I p40x protein (34) , and analyzed by RNase protection as described by Ondek et al . (35) using gel-purified probes specific for the CAT mRNA .
P1asmids, Transfections, and CAT Assays. TGF-01-CAT constructs, phTG5, phTG H/B, phTG16, phTG17, phTG19, phTG22, phTG26, and phTG28 (33, 36, 37) , and HTLVI LTR-CAT and pHTLVpX constructs (34) have been described in detail elsewhere. Transfections were performed by the C2P04 precipitation method (38) for A-549 cells and by the DEAE-dextran procedure, as described by Cross et al . (39) , for Jurkat and K-562 cells. Approximately 107 cells of each type were transfected with 10 ug of plasmid DNA, together with 3 lAg of the pHTLVI-Tax plasmid. After 40 h, cells were harvested and extracts were assayed for CAT activity according to the method of Gorman et al . (40) . In some experiments, transfected frequencies were monitored by cotransfection with 1 lrg of pSVGH, agrowth hormone expression vector.
Quantitation of the TGF,81 and TGR,82 Secreted by Cells in Culture. TGF-O secreted from the cells was quantitated by the sandwich ELISAs (SELISAs) for TGF-01 and TGF-{32 using both turkey and rabbit neutralizing polyclonal antibodies against native TGF-/3s (41) .
Results
Effect of Tax on TCF,81 Promoter Constructs and Ideritification of TGF,81 Promoter Regions Requiredfor Tax Transactivation. To understand the effect of the HTLV-1 provirus on the TGF-a1 gene, we cotransfected plasmids containing sequences located 5' to the upstream transcriptional start site (the first promoter, phTG5), and located between the two major transcriptional initiation sites of the TGF-01 gene (the second promoter) linked to the bacterial CAT gene (40) ( 2) . It thus appears that transactivation of the TGF-R1 promoter by the Tax protein is at the transcriptional level .
To identify the specific sequences required for Tax transactivation, we used a series of 5' deletion mutants of the TGF-#1 promoters linked to the CAT gene . As shown in Fig. 3 , the first promoter sequences of the TGF-01 gene positioned between nucleotides -453 and -323 were required for optimal CAT induction by Tax protein . The second promoter of the TGF-,Q1 gene was also transactivated by Tax protein .
The expression of plasmids phTG16, phTG17, phTG19, and phTG26 was increased by the Tax protein, whereas the Tax stimulation dropped almost to the basal level when sequences between +150 and +173 were deleted (phTG22) . Tax stimulation again dropped substantially upon deletion of sequences between +247 and +267. These data suggest that the majority of activation by Tax protein is mediated by promoter sequences between positions -453 and -323 of the first promoter and between positions +150 and +173 and +247 and +267 in the second promoter of the TGF-#1 gene. These critical promoter sequences required for the Tax induction in TGF-01 promoters contain sequence elements (TGTCTCA, -371 to -365 ; TGAGACGA, +160 to +167; and TGAGACT, +256 to +262) with a high degree of similarity to the AP-1 complex binding sites found in the collagenase (42) and metallothionein promoters (43) . These TGF-01 promoter elements play an important role in transcriptional activation of the TGF-01 gene mediated by various inducers, including TGF-01 (36, 37, 44 ) and 12-O-tetradecanoyl-phorbol-13-acetate (TPA) (36, 45) . fected by the DEAE-dextran method (10 1Ag of DNA per 107 cells) into either Jurkat or K-562 cells, or by the calcium phosphate coprecipitation method into A-549 cells, either with or without 3 j ug of p40'-producing plasmid. CAT activity, expressed as the percentage of chloramphenicol transacetylation, was measured after 40 h, for a representative experiment using A549 cells, as described (40) . Transfection frequencies were monitored by cotransfection with 1 ug of pSVGH, a growth hormone expression vector. (Fig. 4, A and B) , and in four of four HTLV I-infected cell lines (Fig. 4 C) . TGF-(31 mRNA was detected in the PHA/ PMA induced Jurkat RNA (positive control), whereas uninduced Jurkat cells, control resting T cells, and control PBMC had low levels of TGF-/31 mRNA (Fig. 4 , A and C). Significantly higher TGF-/31 mRNA levels were observed in freshly isolated ATL PBMC in comparison with control PBMC or control resting T cells (Fig . 4 A) . In RNA from five of six of the ATL cases, TGF-a1 mRNA levels were equal to or greater than the levels seen in ATIrderived cell lines or induced Jurkat cells (Fig. 4, B (A and B) ; HTLV-1-infected T cell lines (MT1, MT2, MT4, and HUT102) (C); and noninfected T cell line Gurkat) (C) were hybridized to a radiolabeled TGF-01 probe.
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Transactivation of the Transforming Growth Factor 01 Gene T and B cells were cultured at 37°C for 48 h in serum-free medium . The culture supernatant was harvested by centrifugation, and the amounts of ME-01 and TGF-02 secreted from the cells were measured by SELISA. Supernatants conditioned by unactivated T cells or B cells contain low levels of TGF-0 biological activity (<0 .5 pM), while supernatants from PHA activated T cells and SAC-activated B cells had levels 10-50-fold higher (Table 1 ) (20) . However, as shown in Table 1 , supernatants from the unstimulated PBMC derived from the ATL patients secreted levels of TGF-0 equal to or substantially greater than those of the activated T and B cells . Since the increased TGF-0 secretion from the ATIT derived PBMC could possibly result from the induction of Cells were plated at 106/ml and cultured for 48 h in serum-free media as described in Materials and Methods. Levels of TGF-01 and 02 peptides were measured by specific and sensitive SELISAs. Conditioned media TGF-01 and TGF-/32 measured by the SELISAs were calculated using cubic and quadratic regression equations with Dynatech's immunosoft program. All values shown represent the average of the three determinations ± 1 SD from the mean.
TGF-0 production in another cell type present in the PBMC preparation, we generated a highly purified population of malignant ATL cells and examined the level of TGF-01 secreted (ATL8) . The level of TGF-/31 secreted from the purified leukemic cells was much higher than that of unactivated T cells . The type of TGF-0 secreted by HTLVI-infected cells was determined by a SELISA using antisera specific for either TGF-01 or TGF-02 (41). TGF-0 secreted from all of the tested cells was predominantly TGF-S1; levels ofTGF-(32 were low to undetectable (Table 1 ). These results demonstrate that HTLVI-infected cells secrete relatively large amounts ofTGF-01 protein .
Discussion
The present studies strongly suggest that Tax protein activates the gene for TGF-S1 through a distinct DNA element, the TPA-responsive element (TRE), which is also required for activation by TPA or TGF-01 . THE motifs have been shown to bind the AP-1 complex consisting of the Jun/Fos dimer. In both the first and second promoters of the TGF-01 gene, the DNA motifs that mediate the responses to Tax protein and to TGF-01 autoinduction are identical .
The HTLVI Tax protein (27) (28) (29) is a potent transcriptional activator of its own long terminal repeat (LTR) promoter and a number of cellular genes. It is known that the transactivation function of Tax is highly pleiotropic since Taxresponsive genes (e.g., IL2-Roi [39, 46] , 11,2 [46] [47] [48] , GM-CSF [49] , and IIr3 [50] ) share little sequence homology in their regulatory sequences . We have documented that the essential Tax-responsive element within the HTLVI LTR con- 12 5 Kim et al .
sists of a triply reiterated TGACGTCT motif (51, 52) . In fact, it has been experimentally demonstrated that the HTLVI LTR is both a CAMP and a phorbol ester responsive element . Recently, we have found that the TGACGTCT element for the HTLVI LTR is a bona fide binding site for AP-1 and functionally responds to activation by v~un aeang et al., manuscript in preparation). Our present observation that Tax also activates the TGF-01 promoter through the AP-1/Jun motifs suggests that this described transactivation phenomenon may be physiologically relevant and may functionally occur through the signal transduction pathway that is postulated in Tax activation of the HTLVI LTR (51, 52) . Our results are also strengthened by the observation that expression ofc-fos, which is one of the components of the AP-1 complex that binds to the TRE, is also transactivated by the Tax protein (53) . The mechanism for interaction of Tax protein with the AP-1 complex remains to be clarified. It is unlikely that Tax binds to DNA directly or leads to de novo synthesis of cellular factors that confer activation. One possible hypothesis might be that Tax expression results in the post-translational modification of a constitutively expressed transcription factor from an inactive to an active form, or that Tax participates directly in the formation of an active transcription complex. Thus, transactivation of TGF-ail gene expression by Tax could proceed via an indirect, rather than direct, mechanism.
We also demonstrated high levels of constitutive expression ofthe TGF-(31 gene in leukemic cells from ATL patients, as well as in HTLVI-infected T cell lines, confirming previous results (14) . Since TGF-0 mRNA levels from other leukemic cells, such as acute myelogeneous leukemia, acute lymphatic leukemia, and chronic myelogeneous leukemia, were low to undetectable (14) , the fact that ATL cells produced high levels of TGF-(31 mRNA suggests that this event is directly induced by HTLVI . In contrast to primary tumor cells, longterm ATL cell lines produced variable amounts of TGF-01 mRNA.
The altered regulation by Tax of a variety of host genes, including those associated with T cell activation and proliferation, has led to speculation that Tax expression plays an es sential role in the pathogenesis of HTLVI-associated diseases. The high level of TGF-/31 gene expression associated with ATL cells suggests that this mediator may also play an important role in the pathological changes associated with this leukemia. However, efforts to date have failed to demonstrate Tax mRNA in fresh leukemic cells (54) . Thus, expression of TGF-(31 in the circulating cells of ATL patients is similar to the IIT2-Rot (Tac), in that high levels of constitutive expression ofboth genes are easily demonstrated from fresh leukemic cells in the absence of Tax. Theoretically, transactivation of TGF-/31 and IIr2-Ra (Tac) could occur early in the course of HTLVI infection, priming the T cells for a second "hit", resulting in leukemogenesis. Thus, the circulating ATL cells would be in a terminally differentiated, autonomous state and may no longer require Tax expression for proliferation . Alternatively, Tax expression may be limited to microenvironments inwhich cells are rapidly dividing, i.e., malignant lymph nodes . Finally, as a regulatory message, Tax mRNA may be present in minute quantities and may have a very short half- In contrast, nonmitogen-activated HTLVI-infected cell lines and freshly isolated leukemic cells from patients with ATL secreted levels of TGF-(3 equivalent to and/or in excess of mitogen-activated lymphocytes. Both normal lymphocytes and the HTLVI-infected cells produced exclusively TGF-0l, with the exception of small amounts of TGF-02 produced by MT2 cells and one of the patient's cells.
The TGF-0 produced by normal lymphocytes is predominantly in a latent form that is unable to bind to the TGF-/3 receptor. This latent form is a complex between the remainder of the TGF-0 precursor, mature TGF-a, and a third TGF-a binding protein (56, 57) . In vitro, exposure to low pH or heat results in dissociation of the complex and the release of active TGF-IQ (56) . The mechanism by which TGF-0 is activated in vivo is poorly understood, but it may involve proteolytic enzymes or exposure to the appropriate microenvironment . Similar to normal lymphocytes, the TGF-0 produced by the ATL cell lines appears to be predominantly latent. All the supernatants used in the SELISA were acid or heat inactivated before testing, which would activate any latent TGFLS present . However, the supernatants were also tested using a CCD64 assay (58), a biologic assay that measures active TGF-0 . Active TGF-a was detected in the supernatants conditioned by the ATL cells only after heat activation (A. B. Roberts, unpublished observation). This is in contrast to the findings of Niitsu et al. (14) , who reported that much of the TGF-a produced by ATL cells was active. The distinction between the production of predominantly latent vs. active TGF-a is important . The half-life of active TGF-(3 in the circulation is exceedingly short (N3 min) (59), while the half-life of latent TGF-/3 is nearly 2 h (L. Wakefield, personal communication) . Thus, the production of active TGF-0 by a cell is likely to have an effect only in the immediate environment of the secreting cells, while the production of latent TGF-a by a cell may result in a more long-range effect.
Cellular and humoral immune responses are markedly impaired in patients with ATL. Abnormalities include disordered helper and suppressor T cell function, impaired mitogen responsiveness, decreased killer cell induction, and depressed B cell Ig synthesis (60) (61) (62) . Additionally, immunosuppressive factors have been detected in HTLVI-infected ATL sera and ATL culture supernatants (63, 64) . X-irradiated leukemic cells from ATL patients suppress the PWM-induced Ig synthesis by control PBMC (65) . The excessive production of TGF-(3 by ATL cells in vivo could account for many of these immunological abnormalities. TGF-(3 has been shown in vitro to impair both T and B cell proliferation, to inhibit NK cell induction and cytotoxic T cell induction, and to depress B cell Ig secretion (19) (20) (21) (22) (23) (24) (25) . The in vitro effects of TGF-/3 and the observed immunosuppression in ATL patients are strikingly similar. Additionally, the excessive production ofTGF-(3 by ATL cells may offer a selective advantage. Increased levels of TGF-a may suppress the very immune cells responsible for the elimination of the tumor cells.
TGF-0s are important in the regulation of many other cell types as well. Of interest to this study, they have been found to be important in the processes ofbone resorption and new bone formation (17, 18) . One of the important clinical features of ATL patients is the frequent hypercalcemia (1, (3) (4) (5) (6) (7) (8) (9) . The findings that bone resorbing factors are present in the in vitro culture supernatants of ATL cells has suggested that osteoclast-activating factors are produced by the ATL cells themselves. Several factors, including 1140 and TNF-(3, have been detected in these supernatants and have been suggested to be involved in the pathogenesis of the hypercalcemia (12, 13) . It is likely that TGF-(3 is involved as well, either by itself or in combination with these other cytokines. To establish firmly a relationship between TGF-IQ production and ATL associated changes in calcium metabolism and immune competence, prospective studies correlating TGF-(3 production with changes in bone turnover, osteoclast activation, and immune function are needed.
In conclusion, we have shown that the increased production of TGF-0 by ATL cells and some HTLVI-infected cell lines may be related to the transactivation ofthe TGF-0 promoter by the HTLVI-derived protein, Tax . Using deletion mutants of the TGF-0 promoter, we have mapped the Taxresponsive element to the AP-1-binding sites in the TGF-(3 promoter. The excessive production of TGF-ail may be important in the pathogenesis of the immunosuppression and hypercalcemia associated with ATL.
